Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, treatment with XTANDI (enzalutamide) plus ADT was associated with a 66% probability of survival …

EODHD | 22 May 2025

Daiichi Sankyo Continues to Transform Treatment Landscape for Patients with Cancer with Practice-Changing Data at ASCO

Late-breaking data from DESTINY-Breast09 and DESTINY-Gastric04 phase 3 trials showcase how ENHERTU will potentially redefine standard of care for first-line HER2 positive metastatic breast cancer and second-line HER2 positive metastatic gastric cancer Investor meeting to discuss ASCO presentations and oncology development updates BASKING RIDGE, …

EODHD | 22 May 2025

Wheaton Precious Metals Publishes 2024 Sustainability Report and 2024 Climate Change Report

VANCOUVER, BC, May 22, 2025 /CNW/ - Wheaton Precious Metals™ Corp. ("Wheaton" or the "Company") today published both its 2024 Sustainability Report and 2024 Climate Change Report. "Wheaton's 2024 Sustainability and Climate Change Reports highlight how we integrate ESG considerations into our decision making …

EODHD | 22 May 2025

CMS to recover ‘uncollected overpayments’ amid Medicare audits

When announcing a “significant expansion” of its auditing efforts for Medicare Advantage plans, the Centers for Medicare and Medicaid Services said it will collaborate with the Department of Health and Human Services Office of Inspector General to recover uncollected overpayments identified in past audits. …

EODHD | 22 May 2025

Why Are Coinbase (COIN) Shares Soaring Today

What Happened? Shares of blockchain infrastructure company Coinbase (NASDAQ:COIN) jumped 6.6% in the afternoon session after stocks tied to digital assets surged as Bitcoin, the world's largest cryptocurrency by market cap, reached a new all-time high, edging past the $110,000 mark. This rally also …

EODHD | 22 May 2025

Target’s Troubles Leave Analysts Most Negative Since 2018

(Bloomberg) -- Wall Street’s enthusiasm for Target Corp. is at its lowest in more than six years, as disappointing earnings from the big-box retailer spur a series of analyst downgrades. Most Read from Bloomberg NY Private School Pleads for Donors to Stay Open After …

EODHD | 22 May 2025

JP Morgan Keeps Faith in UnitedHealth (UNH) Amid Regulatory Reviews

On May 22, JP Morgan analyst Lisa Gill reiterated her optimistic view on UnitedHealth Group Inc. (NYSE:UNH) despite the recent issues, including the allegations made in a report by The Guardian. On May 21, after the market closed, the Centers for Medicare and Medicaid …

EODHD | 22 May 2025

Was Jim Cramer Right About Danaher Corporation (DHR)?

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 15, Mad …

EODHD | 22 May 2025

Copart (NASDAQ:CPRT) Reports Sales Below Analyst Estimates In Q1 Earnings

Online vehicle auction company Copart (NASDAQ:CPRT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $1.21 billion. Its GAAP profit of $0.42 per share was in line with analysts’ consensus estimates. Is now the time to buy …

EODHD | 22 May 2025

S&P 500 Gains and Losses Today: Coinbase Stock Climbs as Cryptocurrency Prices Surge

Robert Nickelsberg / Contributor / Getty Images Monitors display Coinbase signage during the company's initial public offering (IPO) at the Nasdaq market site April 14, 2021 in New York City. Key Takeaways The S&P 500 slipped less than 0.1% on Thursday, May 22, after …

EODHD | 22 May 2025